This randomized clinical trial assesses the efficacy and safety of continuous bevacizumab treatment plus standard of care vs standard of care alone beyond first progression in patients with non–small cell lung cancer.
https://ift.tt/2onnstG
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: Free Radical Biology and Medicine, Volume 110 Author(s): Lucía Fernández-del-Río, Anish Nag, Elen...
-
Publication date: Available online 5 September 2017 Source: Journal of Proteomics Author(s): Melissa J. Wilking-Busch, Mary A. Ndiaye, Xia...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου